Search Results

There are 8236 results for: content related to: Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?

  1. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat

    Liver International

    Volume 34, Issue 4, April 2014, Pages: 521–534, Ying-Ying Yang, Ren-Shyan Liu, Pei-Chang Lee, Yi-Chen Yeh, Yi-Tsau Huang, Wei-Ping Lee, Kuei-Chuan Lee, Yun-Cheng Hsieh, Fa-Yauh Lee, Tat-Wei Tan and Han-Chieh Lin

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12299

  2. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  3. MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1077–1086, Valentina Vaira, Massimo Roncalli, Carlo Carnaghi, Alice Faversani, Marco Maggioni, Claudia Augello, Lorenza Rimassa, Tiziana Pressiani, Gaia Spagnuolo, Luca Di Tommaso, Stefano Fagiuoli, Elena Rota Caremoli, Massimo Barberis, Roberto Labianca, Armando Santoro and Silvano Bosari

    Version of Record online : 20 JUL 2014, DOI: 10.1111/liv.12636

  4. You have free access to this content
    Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

    Liver International

    Volume 35, Issue 10, October 2015, Pages: 2203–2217, Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux and Christèle Desbois-Mouthon

    Version of Record online : 23 JUL 2015, DOI: 10.1111/liv.12903

  5. Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment

    Liver International

    Volume 35, Issue 8, August 2015, Pages: 2001–2008, Francesca V. Negri, Barbara Dal Bello, Camillo Porta, Nicoletta Campanini, Sandro Rossi, Carmine Tinelli, Guido Poggi, Gabriele Missale, Silvia Fanello, Stefania Salvagni, Andrea Ardizzoni and Silini Enrico Maria

    Version of Record online : 22 JAN 2015, DOI: 10.1111/liv.12778

  6. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)

    Liver International

    Volume 33, Issue 3, March 2013, Pages: 327–337, Joong-Won Park, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-Francois H. Geschwind, Khean Lee Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng and Ann-Lii Cheng

    Version of Record online : 18 JAN 2013, DOI: 10.1111/liv.12083

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 33, Issue 5, 808, Version of Record online: 7 APR 2013

  7. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 1036–1047, Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani and on behalf ofBLOG (Bologna Liver Oncology Group)

    Version of Record online : 20 MAY 2014, DOI: 10.1111/liv.12574

  8. Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma

    Liver International

    Francesca Romana Ponziani, Sherrie Bhoori, Alessandro Germini, Marco Bongini, Maria Flores, Carlo Sposito, Antonio Facciorusso, Antonio Gasbarrini and Vincenzo Mazzaferro

    Version of Record online : 20 JAN 2016, DOI: 10.1111/liv.13052

  9. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2147–2154, Yu Yang, Feng Wen, Jianliang Li, Pengfei Zhang, Wenhui Yan, Ping Hao, Feng Xia, Feng Bi and Qiu Li

    Version of Record online : 7 MAR 2015, DOI: 10.1111/liv.12805

  10. You have free access to this content
    Treatment of hepatocellular carcinoma: beyond international guidelines

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 129–138, Massimo Colombo and Angelo Sangiovanni

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12713

  11. You have free access to this content
    Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment

    Liver International

    Volume 35, Issue 6, June 2015, Pages: 1646–1660, Sarah Raevens, Anja Geerts, Christophe Van Steenkiste, Xavier Verhelst, Hans Van Vlierberghe and Isabelle Colle

    Version of Record online : 16 FEB 2015, DOI: 10.1111/liv.12791

  12. You have full text access to this OnlineOpen article
    Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2155–2166, Joong-Won Park, Minshan Chen, Massimo Colombo, Lewis R. Roberts, Myron Schwartz, Pei-Jer Chen, Masatoshi Kudo, Philip Johnson, Samuel Wagner, Lucinda S. Orsini and Morris Sherman

    Version of Record online : 25 MAR 2015, DOI: 10.1111/liv.12818

  13. You have free access to this content
    Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 834–843, Vinicio Carloni, Tu Vinh Luong and Krista Rombouts

    Version of Record online : 12 FEB 2014, DOI: 10.1111/liv.12465

  14. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 950–957, Ju-Yeon Cho, Yong-Han Paik, Ho Yeong Lim, Young Gon Kim, Hyo Keun Lim, Yang Won Min, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik and Byung Chul Yoo

    Version of Record online : 21 APR 2013, DOI: 10.1111/liv.12168

  15. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 605–615, Katsutoshi Sugimoto, Fuminori Moriyasu, Kazuhiro Saito, Nicolas Rognin, Naohisa Kamiyama, Yoshihiro Furuichi and Yasuharu Imai

    Version of Record online : 11 JAN 2013, DOI: 10.1111/liv.12098

  16. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  17. You have free access to this content
    Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1133–1152, Gianluigi Mazzoccoli, Manlio Vinciguerra, Jude Oben, Roberto Tarquini and Salvatore De Cosmo

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12534

  18. You have free access to this content
    Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 174–183, Ann Lii Cheng, Deepak Amarapurkar, Yee Chao, Pei-Jer Chen, Jean-François Geschwind, Khean L. Goh, Kwang-Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun-Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T. Poon, Chee-Kiat Tan, Tawesak Tanwandee, Gaojun Teng and Joong-Won Park

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12314

  19. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo

    Liver International

    Volume 34, Issue 3, March 2014, Pages: 447–461, Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs-Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt-Wolf and Maria A. Gonzalez-Carmona

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12284

  20. You have free access to this content
    Liver tissue engineering and cell sources: issues and challenges

    Liver International

    Volume 33, Issue 5, May 2013, Pages: 666–676, Anwar A. Palakkan, David C. Hay, Anil K. PR, Kumary TV and James A. Ross

    Version of Record online : 15 MAR 2013, DOI: 10.1111/liv.12134